Upgrade Rate and Long-term Outcomes of Lobular Neoplasia

S Ardila, A Chen, T Maramara, D Henry… - Current Breast Cancer …, 2024 - Springer
Abstract Purpose of Review Lobular neoplasia is a risk factor for breast cancer development,
but its management remains controversial as upgrade rates differ depending on the subtype …

Immediate and delayed risk of breast cancer associated with classic lobular carcinoma in situ and its variants

HL Chung, LP Middleton, J Sun… - Breast Cancer Research …, 2024 - Springer
Objective To determine the risk of breast cancer due to lobular carcinoma in situ (LCIS).
Methods This retrospective IRB-approved study identified cases of LCIS after percutaneous …

[PDF][PDF] Causal association between complement system FHR-5, CTRP9, and breast carcinoma in situ: a Mendelian randomization study.

YL Peng, H Li, P Sun, HD Zhang, D Li… - European Review for …, 2024 - europeanreview.org
OBJECTIVE: Breast carcinoma in situ accounts for a significant number of new-ly diagnosed
breast cancer cases. However, the cause of this type of cancer is unclear, which has led to …

[PDF][PDF] 2022. V4 版美国国立综合癌症网络乳腺癌临床实践指南: 外科部分解读

刘晓岭, 邓爱诗, 韦伟 - 临床外科杂志, 2023 - lcwkzz.com
美国国立综合癌症网络(nationalcomprehensive cancernetwork, nccn) 指南是美国肿瘤领域
临床决策的标准, 指南每年持续更新, 以临床研究数据为依据, 是世界各国肿瘤科医生重要参考 …

De-escalation of Surgical Intervention and Contemporary Management Recommendations for Lobular Neoplasia, Atypical Ductal Hyperplasia, and Ductal Carcinoma …

AL Amin, ME Miller - Current Breast Cancer Reports, 2023 - Springer
Abstract Purpose of Review In which patients is it oncologically safe to offer active
surveillance instead of surgery for DCIS or a benign breast lesion with upgrade potential …

In Search of Calcifications: Histologic Analysis and Diagnostic Yield of Stereotactic Core Needle Breast Biopsies

F Yilmaz, SM Hacking, L Donegan… - American Journal of …, 2023 - academic.oup.com
Objectives Stereotactic core needle biopsy (SCNB) is used in the diagnostic assessment of
suspicious mammographic calcifications to rule out breast ductal carcinoma in situ (DCIS) …